InsiderFlow

BRVE

BRVE$26.90-0.12 (-0.44%)
Prev Close$27.02·MCap·P/E·Vol199.4K·Yield

Buys (12M)

10

$159.03M

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$159.03M

Active Insiders

10

last 12 mo

Over the past 12 months, insider activity at BRVE (BRVE) has been exclusively buying, with 10 insider purchases totaling $159.03M and 0 insider sales totaling $0.00. The most recent insider transaction was by AH Bio Fund IV, L.P. (10 percent owner), who purchased $19.80M worth of shares on Aug 11, 2026.

BRVE Insider Trading Activity

DateInsiderTypeValue
Aug 11, 2026 AH Bio Fund IV, L.P.Buy$19.80M1.6% OS
Aug 11, 2026 ORBIMED ADVISORS LLCBuy$34.92M2.7% OS
Aug 11, 2026 Chimovits ErezBuy$34.92M2.7% OS
Aug 7, 2026 Rickey James PaulBuy$500.0K
Aug 7, 2026 Murdoch TravisBuy$1.50M
Aug 7, 2026 Viehbacher ChristopherBuy$1.50M
Aug 7, 2026 Lubner David CharlesBuy$1000.0K
Aug 7, 2026 Malek David IBuy$75.0K
Aug 7, 2026 Forbion Growth Opportunities Fund III Cooperatief U.A.Buy$64.80M5.1% OS
Aug 7, 2026 Anderson Michele A.Buy$20.0K

BRVE Insider Buying Activity

The following table shows recent insider purchases of BRVE (BRVE) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 11, 2026 AH Bio Fund IV, L.P.Buy$19.80M1.6% OS
Aug 11, 2026 ORBIMED ADVISORS LLCBuy$34.92M2.7% OS
Aug 11, 2026 Chimovits ErezBuy$34.92M2.7% OS
Aug 7, 2026 Rickey James PaulBuy$500.0K
Aug 7, 2026 Murdoch TravisBuy$1.50M
Aug 7, 2026 Viehbacher ChristopherBuy$1.50M
Aug 7, 2026 Lubner David CharlesBuy$1000.0K
Aug 7, 2026 Malek David IBuy$75.0K
Aug 7, 2026 Forbion Growth Opportunities Fund III Cooperatief U.A.Buy$64.80M5.1% OS
Aug 7, 2026 Anderson Michele A.Buy$20.0K

BRVE Insider Selling Activity

The following table shows recent insider sales of BRVE (BRVE) stock reported via SEC Form 4 filings.

No insider selling activity found for BRVE in the last 12 months.

BRVE Insiders

ORBIMED ADVISORS LLC

director, 10 percent owner:

Bought $34.92M
1 tradesLast: Aug 11, 2026
AH Bio Fund IV, L.P.

10 percent owner

Bought $19.80M
1 tradesLast: Aug 11, 2026
Chimovits Erez

director, 10 percent owner:

Bought $34.92M
1 tradesLast: Aug 11, 2026
Viehbacher Christopher

director

Bought $1.50M
1 tradesLast: Aug 7, 2026
Anderson Michele A.

officer: Chief Development Officer

Bought $20.0K
1 tradesLast: Aug 7, 2026
Lubner David Charles

director

Bought $1000.0K
1 tradesLast: Aug 7, 2026
Murdoch Travis

director, officer: CEO and President

Bought $1.50M
1 tradesLast: Aug 7, 2026
Malek David I

director

Bought $75.0K
1 tradesLast: Aug 7, 2026
Rickey James Paul

officer: Chief Financial Officer

Bought $500.0K
1 tradesLast: Aug 7, 2026
Forbion Growth Opportunities Fund III Cooperatief U.A.

10 percent owner

Bought $64.80M
1 tradesLast: Aug 7, 2026